Table 4.

Clinical safety markers

Procedural complications *	0
Creatinine kinase (U/l) †
Baseline	80.5 ± 39.4
6–8 h after cell therapy	180.1 ± 78.9
12–16 h after cell therapy	162.9 ± 58.8
20–24 after cell therapy	145.1 ± 58.6
Creatinine kinase -MB (ng/ml) ‡
Baseline	1.11 ± 0.57
6–8 h after cell therapy	1.33 ± 0.67
12–16 h after cell therapy	1.33 ± 1.05
20–24 after cell therapy	1.22 ± 1.03

Values are expressed as mean ± SD.

^*Reduction in TIMI flow, dissection, aneurysm and thrombosis.

^†upper normal limit = 232.

^‡upper normal limit = 7